Searched for
STRIDES PHARMA Q3 RESULT
India known as nation with world's largest healthcare programme: PM ModiPrime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such ...- A 2026 World Cup tech makeover is turning every player into a digital twin, with 16 cameras, a 13-gram smart ball, and millimeter-level scans that could settle the sport’s tightest callsThe World Cup introduces a revolutionary AI offside system. Players are now 3D scanned, and a smart ball tracks every touch. This technolog...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- UAE Lottery winners list (11-06-2026): Check Pick 3, 4 winning numbers, draw timings, total price amount and other detailsUAE Lottery winners list today: UAE Pick 3 and 4 lottery results for June 11, 2026, are now available. Players who participated in the Pick...
- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- MTAR Tech shares crash 9% after 280% rally in a year. What’s spooking investors today?MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...
- Zee Entertainment shares rise over 3% ahead of FIFA World Cup, Rs 2,300-crore fundraising plansZee Entertainment Enterprises' shares rose after its board approved raising at least Rs 2,300 crore to fund strategic initiatives and bolst...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- Rupee to average around 96/USD in FY27; risks from oil, dollar persist: Motilal OswalThe Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Flexi-staffing industry in India sees 8% YoY growth in new employment in 2025-26: ISF reportThe push for formal employment, strongly supported by the staffing industry, has been instrumental in bringing more workers into structured...
- 'Indian diplomacy works 24/7 for nation': EAM Jaishankar shares foreign policy transformations in last 12 yearsExternal Affairs Minister S Jaishankar on Tuesday shared key transformations in India's foreign policy and the Ministry of External Affairs...
- Indian employers turn cautious for July-September quarter amid global uncertainties: ReportLooking ahead to the July-September period, India's hiring scene is poised for a slowdown as employers adopt a wait-and-see stance amidst g...
- Bonus issue alert! Brigade Enterprises sets record date for 1:3 bonus share rewardBrigade Enterprises has fixed June 17 as the record date for its 1:3 bonus share issue after receiving shareholder approval through an e-vo...
- Infosys dividend alert! Last date to buy IT giant's shares to secure Rs 25/sh payoutInfosys has set June 10 as the record date to determine shareholder eligibility for its final dividend of Rs 25 per share. Since shares mus...
- The AI play no one is talking about: Why BofA is snapping up power & metals instead of ITBofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...
- Earnings slowdown in FY27? JM Financial lists 5 sectors which must do the heavy liftingNifty 50 earnings growth fell short of expectations in FY25 and FY26. While Q4 FY26 results led to an upward revision for FY27E Nifty 50 EP...
- PhysicsWallah revises lending strategy, to partner with NBFCs for student loansIn a filing on June 4, the company said it will now tie up with third-party non-banking financial companies (NBFCs) instead of lending thro...
- Buy financials, healthcare, and manufactured exports; Pramod Gubbi on investing in a tricky marketIndia's Q4 earnings show recovery signs, with Nifty 100 profits up 13%. However, macro headwinds like rising crude oil prices and a depreci...
Load More
